How many email patterns does Dalriada Drug Discovery use?

Dalriada Drug Discovery uses 4 known email patterns.

What domain does Dalriada Drug Discovery use for work emails?

Dalriada Drug Discovery uses dalriadatx.com for work email addresses.

Most Common Email Formats at Dalriada Drug Discovery

The most accurate and popular Dalriada Drug Discovery's email format is First.Last@dalriadatx.com (ex. John.Doe@dalriadatx.com). Dalriada Drug Discovery also uses First.Middle@dalriadatx.com (ex. John.Michael@dalriadatx.com) as email structures. Dalriada Drug Discovery uses up to 4 different email patterns.

Dalriada Drug Discovery Email Formats	Example	Percentage
First.Last@dalriadatx.com	John.Doe@dalriadatx.com	94%
First.Middle@dalriadatx.com	John.Michael@dalriadatx.com	3%
First@dalriadatx.com	John@dalriadatx.com	2%
First.L@dalriadatx.com	John.D@dalriadatx.com	1%

Dalriada Drug Discovery Email Formats

Example

Percentage

First.Last@dalriadatx.com

John.Doe@dalriadatx.com

94%

First.Middle@dalriadatx.com

John.Michael@dalriadatx.com

First@dalriadatx.com

John@dalriadatx.com

First.L@dalriadatx.com

John.D@dalriadatx.com

Frequently Asked Questions

What does Dalriada Drug Discovery do?

Dalriada Drug Discovery was founded in 2017. operates in the Biotechnology Research industry, along with similar companies like ChemaxonQualigen TherapeuticsCalithera Biosciences. You can visit dalriadatx.com. Explore Dalriada Drug Discovery's company overview page for more information.

What is Dalriada Drug Discovery's email address format?

Dalriada Drug Discovery's email format typically follows the pattern of First.Last@dalriadatx.com; this email format is used 94% of the time. Other contacts within LeadIQ's database had email formats such as First.Middle@dalriadatx.comFirst@dalriadatx.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Dalriada Drug Discovery have currently?

Dalriada Drug Discovery has approximately 41 employees as of July 2026. Key team members to contact include Ceo, Co-Founder: D. K.Chief Strategy Officer: R. K.Chief Financial Officer: K. D. F.. For more team information and contact data, explore Dalriada Drug Discovery's employee directory with LeadIQ.

Dalriada Drug Discovery Email Format

Biotechnology ResearchOntario, Canada11-50 Employees

Dalriada Drug Discovery is a biotechnology research company focused on early-stage small molecule discovery. It operates a TURN-KEY model that aligns R&D with business objectives and IP strategy, with all development activities conducted in Mississauga, Ontario. It assembles focused teams in medicinal chemistry, biology, and ADME to accelerate project progression and support global innovators, including startups and larger biotech and pharmaceutical partners.

Recent developments include the public launch of iCLASS, a live-cell platform for early-stage discovery, announced in April 2026. Dalriada has also announced collaborations with SpiroChem AG and Toposbio in 2026 to support discovery against challenging targets.

Most Common Email Formats at Dalriada Drug Discovery

Frequently Asked Questions

What does Dalriada Drug Discovery do?

What is Dalriada Drug Discovery's email address format?

How many employees does Dalriada Drug Discovery have currently?

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

Dalriada Drug Discovery Email Format

Verify Dalriada Drug Discovery email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Most Common Email Formats at Dalriada Drug Discovery

Frequently Asked Questions

What does Dalriada Drug Discovery do?

What is Dalriada Drug Discovery's email address format?

How many employees does Dalriada Drug Discovery have currently?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Dalriada Drug Discovery Email Format

Verify Dalriada Drug Discovery email addresses

Ready to create more pipeline?

Ready to create more pipeline?

Everything for prospecting,
in one platform.